↓ Skip to main content

Protocol for the development of a CONSORT-equity guideline to improve reporting of health equity in randomized trials

Overview of attention for article published in Implementation Science, October 2015
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (94th percentile)
  • High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

twitter
57 tweeters
facebook
2 Facebook pages
googleplus
1 Google+ user

Citations

dimensions_citation
28 Dimensions

Readers on

mendeley
182 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Protocol for the development of a CONSORT-equity guideline to improve reporting of health equity in randomized trials
Published in
Implementation Science, October 2015
DOI 10.1186/s13012-015-0332-z
Pubmed ID
Authors

Vivian Welch, J. Jull, J. Petkovic, R. Armstrong, Y. Boyer, LG Cuervo, SJL Edwards, A. Lydiatt, D. Gough, J. Grimshaw, E. Kristjansson, L. Mbuagbaw, J. McGowan, D. Moher, T. Pantoja, M. Petticrew, K. Pottie, T. Rader, B. Shea, M. Taljaard, E. Waters, C. Weijer, GA Wells, H. White, M. Whitehead, P. Tugwell

Abstract

Health equity concerns the absence of avoidable and unfair differences in health. Randomized controlled trials (RCTs) can provide evidence about the impact of an intervention on health equity for specific disadvantaged populations or in general populations; this is important for equity-focused decision-making. Previous work has identified a lack of adequate reporting guidelines for assessing health equity in RCTs. The objective of this study is to develop guidelines to improve the reporting of health equity considerations in RCTs, as an extension of the Consolidated Standards of Reporting Trials (CONSORT). A six-phase study using integrated knowledge translation governed by a study executive and advisory board will assemble empirical evidence to inform the CONSORT-equity extension. To create the guideline, the following steps are proposed: (1) develop a conceptual framework for identifying "equity-relevant trials," (2) assess empirical evidence regarding reporting of equity-relevant trials, (3) consult with global methods and content experts on how to improve reporting of health equity in RCTs, (4) collect broad feedback and prioritize items needed to improve reporting of health equity in RCTs, (5) establish consensus on the CONSORT-equity extension: the guideline for equity-relevant trials, and (6) broadly disseminate and implement the CONSORT-equity extension. This work will be relevant to a broad range of RCTs addressing questions of effectiveness for strategies to improve practice and policy in the areas of social determinants of health, clinical care, health systems, public health, and international development, where health and/or access to health care is a primary outcome. The outcomes include a reporting guideline (CONSORT-equity extension) for equity-relevant RCTs and a knowledge translation strategy to broadly encourage its uptake and use by journal editors, authors, and funding agencies.

Twitter Demographics

The data shown below were collected from the profiles of 57 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 182 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Canada 1 <1%
Unknown 181 99%

Demographic breakdown

Readers by professional status Count As %
Researcher 34 19%
Student > Master 25 14%
Student > Bachelor 19 10%
Student > Ph. D. Student 17 9%
Student > Doctoral Student 17 9%
Other 28 15%
Unknown 42 23%
Readers by discipline Count As %
Medicine and Dentistry 44 24%
Nursing and Health Professions 25 14%
Social Sciences 22 12%
Psychology 9 5%
Pharmacology, Toxicology and Pharmaceutical Science 4 2%
Other 21 12%
Unknown 57 31%

Attention Score in Context

This research output has an Altmetric Attention Score of 36. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 June 2017.
All research outputs
#798,675
of 19,745,145 outputs
Outputs from Implementation Science
#160
of 1,643 outputs
Outputs of similar age
#16,286
of 297,920 outputs
Outputs of similar age from Implementation Science
#20
of 268 outputs
Altmetric has tracked 19,745,145 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,643 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 14.5. This one has done particularly well, scoring higher than 90% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 297,920 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 94% of its contemporaries.
We're also able to compare this research output to 268 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 92% of its contemporaries.